Clinical observation of Nianmo Decoction in preventing recurrence of non muscle invasive bladder cancer through PDL1 mediated immune pathway

Phase 1

• Conditions: on muscle invasive bladder cancer

• Registration Number: ITMCTR2000003722
• Lead Sponsor: Yueyang Hospital of Integrated Traditional Chinese and Western medicine, Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. 18 years old <= age <= 85 years old;
2. Non invasive bladder cancer (TA: non-invasive papillary carcinoma; T1: tumor invasion of subepithelial connective tissue) after resection of urethral bladder tumor;
3. According to the syndrome type of traditional Chinese medicine, the diagnosis of Damp heat accumulation;
4. Consent to participate in the trial and sign informed consent.

Exclusion Criteria

1. Postoperative pathology showed bladder tumor with muscle infiltration;
2. Combined with cardiovascular, liver, kidney and hematopoietic system and other serious diseases;
3. Those who participated in or are participating in other clinical trials 3 months ago;
4. The presence of familial genetic diseases or other diseases that may affect this trial;
5. The researcher assessed that it was not suitable to participate in this study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Whether there is tumor recurrence after cystoscopy;

Secondary Outcome Measures

Name	Time	Method
TCM symptom severity score;